Vanguard Group Inc Fulcrum Therapeutics, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,249,607 shares of FULC stock, worth $11.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,249,607

Previous 3,274,592 0.76%

Holding current value

$11.6 Million

Previous $11.7 Million 30.65%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$2.97 - $4.84 $74,205 - $120,927	-24,985 Reduced 0.76%	3,249,607 $15.3 Million
Q3 2024 Nov 13, 2024	BUY	$3.18 - $9.74 $646,967 - $1.98 Million	203,449 Added 6.62%	3,274,592 $11.7 Million
Q2 2024 Aug 13, 2024	BUY	$5.98 - $9.31 $3.18 Million - $4.96 Million	532,478 Added 20.97%	3,071,143 $19 Million
Q1 2024 May 10, 2024	BUY	$6.7 - $12.0 $125,162 - $224,172	18,681 Added 0.74%	2,538,665 $24 Million
Q4 2023 Feb 14, 2024	SELL	$3.18 - $6.86 $391,810 - $845,227	-123,211 Reduced 4.66%	2,519,984 $17 Million
Q3 2023 Nov 14, 2023	BUY	$3.25 - $6.08 $55,789 - $104,369	17,166 Added 0.65%	2,643,195 $11.7 Million
Q2 2023 Aug 14, 2023	SELL	$2.26 - $3.8 $570,564 - $959,355	-252,462 Reduced 8.77%	2,626,029 $8.67 Million
Q1 2023 May 15, 2023	BUY	$2.83 - $13.99 $2.14 Million - $10.6 Million	757,868 Added 35.74%	2,878,491 $8.2 Million
Q4 2022 Feb 10, 2023	BUY	$5.01 - $8.35 $824,300 - $1.37 Million	164,531 Added 8.41%	2,120,623 $15.4 Million
Q3 2022 Nov 14, 2022	BUY	$4.92 - $9.1 $2.1 Million - $3.88 Million	426,430 Added 27.88%	1,956,092 $15.8 Million
Q2 2022 Aug 12, 2022	BUY	$4.2 - $24.0 $108,532 - $620,184	25,841 Added 1.72%	1,529,662 $7.5 Million
Q1 2022 May 13, 2022	BUY	$9.96 - $23.65 $350,213 - $831,581	35,162 Added 2.39%	1,503,821 $35.6 Million
Q4 2021 Feb 14, 2022	BUY	$14.0 - $28.44 $3.01 Million - $6.12 Million	215,233 Added 17.17%	1,468,659 $26 Million
Q3 2021 Nov 12, 2021	BUY	$7.28 - $30.97 $2.52 Million - $10.7 Million	346,391 Added 38.19%	1,253,426 $35.4 Million
Q2 2021 Aug 13, 2021	BUY	$8.09 - $12.0 $7.34 Million - $10.9 Million	907,035 New	907,035 $9.51 Million

Others Institutions Holding FULC

# of Institutions

142

Shares Held

48.8M

Call Options Held

6.8M

Put Options Held

1.73M

View Full List

About Fulcrum Therapeutics, Inc.

Ticker FULC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,038,900
Market Cap $185M
Description
Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...

More about FULC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Fulcrum Therapeutics, Inc. Transaction History